$PODD insiders have traded $PODD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
$PODD insiders have traded $PODD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Insulet Corporation is one of them. Insulet Corporation (NASDAQ:PODD) is a global leader in tubeless insulin ...
Hosted on MSN
Insulet Corporation (PODD) Sees Higher 2025–2026 Revenue and Operating Margins, Says Canaccord
Insulet Corporation (NASDAQ:PODD) ranks among the best medical device stocks to invest in. Canaccord Genuity maintained its Buy rating on Insulet Corporation (NASDAQ:PODD) and boosted its price target ...
Insulet delivers strong fundamentals, with robust revenue growth, high margins, and impressive returns on capital, driven by Omnipod's success. PODD's Q3 results were strong, featuring record revenues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results